Latest News and Press Releases

NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and Ibogaine...

ICP-B794 has demonstrated superior anti-tumor activity in animal models, and exhibited significant tumor-killing effects even in large tumors.

Zurletrectinib demonstrated well-tolerated safety and promising antitumor activity in pediatric/adolescent patients with NTRK/ROS1-altered solid tumors.

Fund IV brings total Assets Under Management (AUM) to c. €9 billion, making GHO the largest healthcare specialist private equity firm headquartered in Europe  GHO has diversified its investor base...

CHASKA, Minn. and TORRANCE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization...

Fund IV brings total Assets Under Management (AUM) to c. €9 billion, making GHO the largest healthcare specialist private equity firm headquartered in Europe  GHO has diversified its investor base...

Kneat to release Q3 2025 financial results on November 12, 2025, host earnings call November 13, 2025.

Company honored by state’s Legislative Manufacturing Caucus for outstanding leadership and contributions to the manufacturing sectorState-of-the-art production line is bringing in new clients, new...

Recognition highlights company’s antithrombotic platform and late-stage programs designed to transform care in oncology and inflammation driven diseases

Symbolic milestone for new buffer media station: Rentschler Biopharma underscores its commitment to the Laupheim headquarters and to the future of Germany and Europe as leading biotechnology...